Article Cited by others

MINI REVIEW

Statin induced diabetes and its clinical implications

Aiman Umme, Najmi Ahmad, Khan Rahat Ali

Year : 2014| Volume: 5| Issue : 3 | Page no: 181-185

   This article has been cited by
 
1 Observational Study of ChondroT's Improvement of Blood Metabolites in High-fat Diet-induced Hyperlipidemia
Chan Suk Yoon, Do Hyeong Kim, Chang Su Na, Ji Won Jeong, Ji Hoon Kim, Sun Gil Kim, Ji Min Choi, Seon Jong Kim
Journal of Korean Medicine Rehabilitation. 2021; 31(1): 81
[Pubmed]  [Google Scholar] [DOI]
2 The Combination of Atorvastatin With Silymarin Enhances Hypolipidemic, Antioxidant and Anti-Inflammatory Effects in a Rat Model of Metabolic Syndrome
I MARKOVÁ, H MALÍNSKÁ, M HÜTTL, D MIKLÁNKOVÁ, O OLIYARNYK, M PORUBA, Z RÁCOVÁ, L KAZDOVÁ, R VECERA
Physiological Research. 2021; : 33
[Pubmed]  [Google Scholar] [DOI]
3 Exogenous Vitamins K Exert Anti-Inflammatory Effects Dissociated from Their Role as Substrates for Synthesis of Endogenous MK-4 in Murine Macrophages Cell Line
Anna Kieronska-Rudek, Agnieszka Kij, Patrycja Kaczara, Anna Tworzydlo, Marek Napiorkowski, Katarzyna Sidoryk, Stefan Chlopicki
Cells. 2021; 10(7): 1571
[Pubmed]  [Google Scholar] [DOI]
4 Sesamol protects MIN6 pancreatic beta cells against simvastatin-induced toxicity by restoring mitochondrial membrane potentials
Girish A. Ghadge, Karthik Gourishetti, Mallikarjuna Rao Chamallamudi, Gopalan Kutty Nampurath, Krishnadas Nandakumar, Nitesh Kumar
3 Biotech. 2020; 10(4)
[Pubmed]  [Google Scholar] [DOI]
5 Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies
Evan B. Stubbs
Experimental Neurology. 2020; 331: 113385
[Pubmed]  [Google Scholar] [DOI]
6 Statin use and safety concerns: an overview of the past, present, and the future
Rubina Mulchandani, Tanica Lyngdoh, Ashish Kumar Kakkar
Expert Opinion on Drug Safety. 2020; 19(8): 1011
[Pubmed]  [Google Scholar] [DOI]
7 Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs
Charlotte Höybye, Paolo Beck-Peccoz, Suat Simsek, Markus Zabransky, Hichem Zouater, Günter Stalla, Robert D Murray
Expert Opinion on Drug Safety. 2020; 19(12): 1539
[Pubmed]  [Google Scholar] [DOI]
8 Statins and Higher Diabetes Mellitus Risk
Kenneth Guber, Gayatri Pemmasani, Aaqib Malik, Wilbert S. Aronow, Srikanth Yandrapalli, William H. Frishman
Cardiology in Review. 2020; Publish Ah
[Pubmed]  [Google Scholar] [DOI]
9 Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study
Camille B Carroll, Douglas Webb, Kara Nicola Stevens, Jane Vickery, Vicky Eyre, Susan Ball, Richard Wyse, Mike Webber, Andy Foggo, John Zajicek, Alan Whone, Siobhan Creanor
BMJ Open. 2019; 9(10): e029740
[Pubmed]  [Google Scholar] [DOI]
10 Optimizing the Pharmacological Profile of New Bifunctional Antihyperlipidemic/Antioxidant Morpholine Derivatives
Alexios N. Matralis, Angeliki P. Kourounakis
ACS Medicinal Chemistry Letters. 2019; 10(1): 98
[Pubmed]  [Google Scholar] [DOI]
11 Screening and management of statin cause a case of prediabetes in an outpatient clinic in Afghanistan: a case report in Andkhoy City
Mohammad Shoaib Hamrah, Mohammad Hassan Hamrah, Mohammad Hussain Hamrah, Toba Dahi, Mohammad Hashem Hamrah
The Egyptian Journal of Internal Medicine. 2019; 31(3): 382
[Pubmed]  [Google Scholar] [DOI]
12 STATIN ADVERSE EFFECTS: MECHANISMS, DIAGNOSIS, PREVENTION AND MANAGEMENT
A. I. Dyadyk,T. E. Kugler,Y. V. Suliman,S. R. Zborovskyy,I. I. Zdykhovskaya
The Russian Archives of Internal Medicine. 2018; 8(4): 266
[Pubmed]  [Google Scholar] [DOI]
13 Pharmacotherapy with Thymoquinone Improved Pancreatic ß-Cell Integrity and Functional Activity, Enhanced Islets Revascularization, and Alleviated Metabolic and Hepato-Renal Disturbances in Streptozotocin-Induced Diabetes in Rats
Adel Galal El-Shemi,Osama Adnan Kensara,Aiman Alsaegh,Mohammed Hasan Mukhtar
Pharmacology. 2018; : 9
[Pubmed]  [Google Scholar] [DOI]
14 Glycemic effects of simvastatin: Where do we stand?
Nor Razida Razali,Hasniza Zaman Huri,Luqman Ibrahim,Shireene Ratna Vethakkan,Bashar Mudhaffar Abdullah
Brazilian Journal of Pharmaceutical Sciences. 2018; 54(1)
[Pubmed]  [Google Scholar] [DOI]
15 Shared Genetic Contribution of Type 2 Diabetes and Cardiovascular Disease: Implications for Prognosis and Treatment
Rona J. Strawbridge,Natalie R. van Zuydam
Current Diabetes Reports. 2018; 18(8)
[Pubmed]  [Google Scholar] [DOI]
16 Examining prescriber perceptions of statin therapy and the potential implications these perceptions may have on guideline adherence
Emily Leppien,Tammie Lee Demler
International Clinical Psychopharmacology. 2018; 33(5): 290
[Pubmed]  [Google Scholar] [DOI]
17 Gender differences in the effects of cardiovascular drugs
J. Tamargo,G. Rosano,T. Walther,J. Duarte,A. Niessner,J.C. Kaski,C. Ceconi,H. Drexel,K. Kjeldsen,G. Savarese,C. Torp-Pedersen,D. Atar,B.S. Lewis,S. Agewall
European Heart Journal - Cardiovascular Pharmacotherapy. 2017;
[Pubmed]  [Google Scholar] [DOI]
18 Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes
Ilaria Campesi,Flavia Franconi,Giuseppe Seghieri,Marco Meloni
Pharmacological Research. 2017; 119: 195
[Pubmed]  [Google Scholar] [DOI]
19 Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy
Zubair Ilyas,Joumana T. Chaiban,Armand Krikorian
Reviews in Endocrine and Metabolic Disorders. 2017; 18(1): 21
[Pubmed]  [Google Scholar] [DOI]
20 Arzneimittelnebenwirkungen: Welche Medikamente diabetogen wirken
Holger Petri
Deutsches Ärzteblatt Online. 2016;
[Pubmed]  [Google Scholar] [DOI]
21 Role of Statins in Glucose Homeostasis and Insulin Resistance
Chanukya Dahagam,Virginia S. Hahn,Aditya Goud,Jason D’Souza,Abdelhai Abdelqader,Roger S. Blumenthal,Seth S. Martin
Current Cardiovascular Risk Reports. 2016; 10(12)
[Pubmed]  [Google Scholar] [DOI]
22 Metabolic effects of bile acid sequestration
Valeria Spinelli,Oscar Chávez-Talavera,Anne Tailleux,Bart Staels
Current Opinion in Endocrinology & Diabetes and Obesity. 2016; 23(2): 138
[Pubmed]  [Google Scholar] [DOI]
23 Toxicity of Atorvastatin on Pancreas Mitochondria: A Justification for Increased Risk of Diabetes Mellitus
Melina Sadighara,Zahra Amirsheardost,Mohsen Minaiyan,Valiollah Hajhashemi,Parvaneh Naserzadeh,Ahmad Salimi,Enayatollah Seydi,Jalal Pourahmad
Basic & Clinical Pharmacology & Toxicology. 2016;
[Pubmed]  [Google Scholar] [DOI]
24 Complications of Diabetes
Konstantinos Papatheodorou,Maciej Banach,Michael Edmonds,Nikolaos Papanas,Dimitrios Papazoglou
Journal of Diabetes Research. 2015; 2015: 1
[Pubmed]  [Google Scholar] [DOI]
25 La diabetogenicidad de las estatinas: żson todas iguales? Estado de la cuestión
Joan Rius Tarruella,Jesús Millán Núńez-Cortés,Juan Pedro-Botet,Xavier Pintó Sala
Clínica e Investigación en Arteriosclerosis. 2015; 27(3): 148
[Pubmed]  [Google Scholar] [DOI]
26 Importancia de la dislipidemia en la enfermedad cardiovascular: un punto de vista
Juan F. Ascaso,Rafael Carmena
Clínica e Investigación en Arteriosclerosis. 2015; 27(6): 301
[Pubmed]  [Google Scholar] [DOI]
27 Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways
Thiago Bruder-Nascimento,Glaucia E. Callera,Augusto C. Montezano,Ying He,Tayze T. Antunes,Aurelie Nguyen Dinh Cat,Rita C. Tostes,Rhian M. Touyz
Clinical Science. 2015; 128(7): 411
[Pubmed]  [Google Scholar] [DOI]
28 Statin use in prediabetic patients: rationale and results to date
Anastazia Kei,Evangelos C. Rizos,Moses Elisaf
Therapeutic Advances in Chronic Disease. 2015; 6(5): 246
[Pubmed]  [Google Scholar] [DOI]
29 Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women
Andrée-Anne Houde,Cécilia Légaré,Simon Biron,Odette Lescelleur,Laurent Biertho,Simon Marceau,André Tchernof,Marie-Claude Vohl,Marie-France Hivert,Luigi Bouchard
BMC Medical Genetics. 2015; 16(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article